Is it only bad when Trump does it?
President Donald Trump issued an executive order (EO) yesterday, May 12, designed to reduce drug prices for American patients and taxpayers alike. The move is a moderate effort to work amicably with pharmaceutical companies to cut taxpayer costs for Medicare and Medicaid, shave price gouging by middlemen, and usher in bipartisan “equity” for American consumers. A few detractors issued paltry opposition, but the policy shift was widely hailed as overdue.
Lowering Drug Prices
Pharmaceutical stocks rose broadly following the president’s announcement, driven by optimism that the EO seeks industry cooperation instead of federal strong-arming. The order directs HHS Secretary Robert F Kennedy Jr. to communicate with industry executives to seek voluntary price reductions that, if successful, will…




